Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries

Histochemistry and Cell Biology

Volumn 127, Issue 6, 2007, Pages 581-589

  Diamanti Kandarakis, Evanthia ^a,e   Piperi, Christina ^a   Patsouris, Efstratios ^a   Korkolopoulou, Penelope ^a   Panidis, Dimitrios ^b   Pawelczyk, Leszek ^c   Papavassiliou, Athanasios G ^a   Duleba, Antoni J ^d  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE   (Greece)

Author keywords

Advanced glycation end products; NF B; Ovaries; PCOS; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR RELA;

ADULT; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GRANULOSA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUTEAL CELL; OVARY FOLLICLE CELL; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; STAINING; THECA CELL; TISSUE SECTION; TUMOR BIOPSY;

ADULT; BIOLOGICAL MARKERS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLYCOSYLATION END PRODUCTS, ADVANCED; GRANULOSA CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; OVARY; POLYCYSTIC OVARY SYNDROME; RECEPTORS, IMMUNOLOGIC; TRANSCRIPTION FACTOR RELA;

EID: 34249937629     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00418-006-0265-3     Document Type: Article

References (58)

1. Abe H, Matsubara T, Iehara N, et al (2004) Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation. J Biol Chem 279:14201-14206
2. Baldwin AS (1996) The NF-κB and IκB proteins: new discoveries and insights. Ann Rev Immunol 14:649-681
3. Bierhaus A, Illmer T, Kasper M, Luther T, Quehenberger P, Tritschler H, Wahl P, Ziegler R, Muller M, Nawroth PP (1997) Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation 96:2262-2271
4. Cai W, He JC, Zhu L, et al (2004) High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox sensitive mitogen-activated protein kinase stimulant in diabetic patients. Circulation 110:285-291
5. Cerami C, Founds H, Nicholl I, et al (1997) Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci USA 94:13915-13920
6. Conway GS, Agrawal R, Betteridge DJ, Jacobs HS (1992) Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 37:119-125
7. Dan Q, Wong RL, Yin S, Chung SK, Chung SS, Lam KS (2004) Interaction between the polyol pathway and non-enzymatic glycation on mesangial cell gene expression. Nephron Exp Nephrol 98:e89-e99
8. Diamanti-Kandarakis E, Dunaif A (1996) New perspectives in polycystic ovary syndrome. Trends Endocrinol Metab 7:267-271
9. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84:4006-4011
10. Diamanti-Kandarakis E, Spina G, Kouli C, Migdalis I (2001) Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy. J Clin Endocrinol Metab 86:4666-4673
11. Diamanti-Kandarakis E, Palioniko G, Alexandraki K, Bergiele A, Koutsouba T, Bartzis M (2004) The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels. Eur J Endocrinol 150:793-798
12. Diamanti-Kandarakis E, Alexandraki K, Protogerou A, Piperi C, Papamichael C, Aessopos A, Lekakis J, Mavrikakis M (2005a) Metformin administration improves endothelial function in women with polycystic ovary syndrome. Eur J Endocrinol 152:749-756
13. Diamanti-Kandarakis E, Piperi C, Creatsas G, Kalofoutis A (2005b) Increased levels of advanced glycation end products in women with polycystic ovary syndrome. Clin Endocrinol 62:37-43
14. Diamanti-Kandarakis E, Piperi C, Alexandraki K, et al (2006) Short-term effect of orlistat on dietary glycotoxins in healthy women and women with polycystic ovary syndrome. Metabolism 55:494-500
15. Duleba AJ, Banaszewska B, Spaczynski RZ, Pawelczyk L (2003) Success of laparoscopic ovarian wedge resection is related to obesity, lipid profile, and insulin levels. Fertil Steril 79:1008-1014
16. Dunaif A, Wu X, Lee A, Diamanti-Kandarakis E (2001) Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab 281:E392-E399
17. Glueck CJ, Wang P, Fontaine RN, Sieve-Smith L, Tracy T, Moore SK (1999) Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. Metabolism 48:1589-1595
18. Harlow CR, Rae M, Davidson L, Trackman PC, Hillier SG (2003) Lysyl oxidase gene expression and enzyme activity in the rat ovary: regulation by follicle-stimulating hormone, androgen, and transforming growth factor-beta superfamily members in vitro. Endocrinology 144:154-162
19. Henmi H, Endo T, Nagasawa K, et al (2001) Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats. Biol Reprod 64:157-162
20. Hori O, Brett J, Slattery T, et al (1995) The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 270:25752-25761
21. Horiuchi S, Araki N, Morino Y (1991) Immunochemical approach to characterize advanced glycation end products of the Maillard reaction; evidence for the presence of a common structure. J Biol Chem 266:7329-7332
22. Ikeda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, Araki T, Ueda S, Horiuchi S (1996) Ne-(carboxymethyl) lysine protein adduct is a major immunological epitope in proteins modified withadvanced glycation end products of the Maillard reaction. Biochemistry 35:8075-8083
23. Karin M, Ben Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-kB activity. Annu Rev Immunol 18:621-663
24. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H (1990) Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87:9010-9014
25. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S (2001) Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 276:20633-20640
26. Kruk PA, Uitto VJ, Firth JD, Dedhar S, Auersperg N (1994) Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix. Exp Cell Res 215:97-108
27. Ligier S, Fortin PR, Newkirk MM (1998) A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE. Br J Rheumatol 37:1307-1314
28. Liu YX (1999) Regulation of the plasminogen activator system in the ovary. Biol Signals Recept 8:160-177
29. Loske C, Neumann A, Cunningham AM, Nichol K, Schinzel R, Riederer P, Munch G (1998) Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J Neural Transm 105:1005-1015
30. Loske C, Gerdemann A, Schepl W, et al (2000) Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide. Eur J Biochem 267:4171-4178
31. Matsuse S, Ohga E, Teramoto S, Fukayama M, Nagai R, Horiuchi S, Ouchi Y (1998) Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis. J Clin Pathol 51:515-519
32. Mohamed AK, Bierhaus A, Schiekofer S, Tritschler H, Ziegler R, Nawroth PP (1999) The role of oxidative stress and NF-kB activation in late diabetic complications. Biofactors 10:157-167
33. Mott JD, Khalifah RG, Nagase H, Shield CF 3rd, Hudson JK, Hudson BG (1997) Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility. Kidney Int 52:1302-1312
34. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, Hayakawa H, Osaka N, Yamamoto H, Ogawa A (1997) Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 51:182-186
35. Neumann A, Schinzel R, Palm D, Riederer P, Munch G (1999) High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression. FEBS Lett 453:283-287
36. Nicholl ID, Bucala R (1998) Advanced glycation endproducts and cigarette smoking. Cell Mol Biol (Noisy-le-grand) 44:1025-1033
37. Oksjoki S, Rahkonen O, Haarala M, Vuorio E, Anttila L (2004) Differences in connective tissue gene expression between normally functioning, polycystic and post-menopausal ovaries. Mol Hum Reprod 10:7-14
38. Pugliese G, Pricci F, Romeo G, et al (1997) Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes 46:1881-1887
39. Puistola U, Martikainen H, Ronnberg L (1986) Type IV collagenolytic activity in human preovulatory follicular fluid. Fertil Steril 45:578-580
40. Read MA, Brownell JE, Gladysheva TB (2000) Nedd8 modification of cul-1 activates SCF(_(TrCP))-dependent ubiquitination of IκB. Mol Cell Biol 20:2326-2333
41. Rodriguez-Garcia J, Requena JR, Rodriguez-Segade S (1998) Increased concentrations of serum pentosidine in rheumatoid arthritis. Clin Chem 44:250-255
42. Rice S, Christoforidis N, Gadd C, et al (2005) Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries. Hum Reprod 20:373-381
43. Sakata N, Imanaga Y, Meng J, Tachikawa Y, Takebayashi S, Nagai R, Horiuchi S, Itabe H, Takano T (1998) Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions. Atherosclerosis 141:61-75
44. Sano H, Higashi T, Matsumoto K, et al (1998) Insulin enhances macrophage scavenger receptor-mediated endocytic uptake of advanced glycation end products. J Bioll Chem 273:8630-8637
45. Schmidt AM, Yan S-D, Wautier JL, Stern DM (1999) Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84:489-497
46. Schmidt AM, Yan S-D, Yan S-F, Stern DM (2000) The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 1498:99-111
47. Siebenlist U, Franzoso G, Brown K (1994) Structure, regulation and function of NF-κB. Ann Rev Cell Biol 10:405-455
48. Singh R, Barden A, Mori T, Beilin L (2001) Advanced glycation endproducts: a review. Diabetologia 44:129-146
49. Tamm I, Trepel M, Cardó-Vila M, et al (2003) Peptides targeting caspase inhibitors. J Biol Chem 278:14401-14405
50. Tsuchida K, Makita Z, Yamagishi S, et al (1999) Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia 42:579-588
51. Tsuji H, Iehara N, Masegi T, et al (1998) Ribozyme targeting of receptor for advanced glycation end products in mouse mesangial cells. Biochem Biophys Res Commun 245:583-588
52. Vlassara H, Brownlee M, Cerami A (1985) High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc Natl Acad Sci USA 82:5588-5592
53. Wu XK, Zhou SY, Liu JX, et al (2003) Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome. Fertil Steril 80:954-965
54. Xiao CW, Ash K, Tsang BK (2001) Nuclear factor-kB-mediated X-linked inhibitor of apoptosis protein expression prevents rat granulosa cells from tumor necrosis factor α-induced apoptosis. Endocrinology 142:557-563
55. Xiao CW, Asselin E, Tsang BK (2002) Nuclear factor kB-mediated induction of flice-like inhibitory protein prevents tumor necrosis factor α-induced apoptosis in rat granulosa cells. Biol Reprod 67:436-441
56. Yamada S, Fujiwara H, Honda T, et al (1999) Human granulosa cells express integrin a2 and collagen type IV: possible involvement of collagen type IV in granulosa cell luteinization. Mol Hum Reprod 5:607-617
57. Yoshida S, Yoshida S, Yamada K, Hamaguchi K, Nishimura M, Hatakeyama E, Tsuchida H, Sakamoto K, Kashiwabara H, Yokoyama T (1998) Immunohistochemical study of human advanced glycation end-products and growth factors in cardiac tissues of patients on maintenance dialysis and with kidney transplantation. Clin Nephrol 49:273-280
58. Yui S, Sasaki T, Araki N, Horiuchi S, Yamazaki M (1994) Induction of macrophage growth by advanced glycation end products of the Maillard reaction. J Immunol 152:1943-1949